Validation requires prospective performance assessment, impact studies, and evaluation of clinical outcomes and workflow effects. Retrospective accuracy is insufficient; randomized or pragmatic trials measure real world benefit and harms. Design trials with appropriate endpoints, subgroup analyses, and monitoring for unintended consequences and equity impacts.
Rigorous validation through trials builds evidence for clinical benefit and informs regulatory and reimbursement decisions. Prospective evaluation strategies to demonstrate safety, effectiveness and clinical impact of AI interventions. Publish negative and positive results, share datasets when possible, and iterate models based on trial findings.
Main Points: AI Validation and Clinical Trials | Prospective trials | Pragmatic designs | Subgroup analysis | Workflow endpoints | Equity monitoring
Quick Facts: Prospective trials reveal real world impact | Subgroup analysis detects disparities | Workflow endpoints matter as much as accuracy | Data sharing accelerates validation | Negative results inform improvement
Topics related to AI Validation and Clinical Trials include clinical trials | validation | equity